A successful haploidentical bone marrow transplantation method in rabbits: Perfusion method plus intra-bone marrow-bone marrow transplantation

Transplant Immunology

Volumn 24, Issue 1, 2010, Pages 33-39

  Cui, Yunze ^a,b   Nakamura, Shuji ^a,b   Shi, Ming ^a   Feng, Wei ^a,c   Cui, Wenhao ^a   Guo, Kequan ^a   Zhang, Yuming ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Haploidentical bone marrow transplantation; Intra bone marrow bone marrow transplantation; Perfusion method; Rabbit; Tolerance induction

Indexed keywords

PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; COLONY FORMING UNIT C; CONTROLLED STUDY; HEMATOPOIESIS; INTERMETHOD COMPARISON; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SURVIVAL RATE; T LYMPHOCYTE; TISSUE PERFUSION;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; FEASIBILITY STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIESIS; HISTOCOMPATIBILITY; HUMANS; MALE; MODELS, ANIMAL; PERFUSION; RABBITS; STEM CELLS; T-LYMPHOCYTES;

EID: 78449250055     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.06.014     Document Type: Article

References (43)

1. Beatty P.G., Clift R.A., Mickelson E.M., et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985, 26(313):765-771.
2. Szydlo R., Goldman J.M., Klein J.P., et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997, 15:1767-1777.
3. Vallera D.A., Soderling C.C., Carlson G.J., et al. Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone. Transplantation 1981, 31:218-222.
4. Kolb H.J., Rieder I., Rolt H., et al. Antilymphocytic antibodies and marrow transplantation. VI. Graft-vs-host tolerance in DLA-incompatible dogs after in vitro treatment of bone marrow with absorbed antithymocyte globulin. Transplantation 1979, 27:242-245.
5. Reisner Y., Kapoor N., Kirkpatrick D., et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983, 61:341-348.
6. O'Reilly R.J., Collins N.H., Kernan N., et al. Transplantation of marrow-depleted T cells by soybean lectin agglutination and E-rosette depletion major histocompatibility complex-related graft resistance in leukemic transplant recipients. Transplant Proc 1985, 17:455-459.
7. + hematopoietic cells using an immunoaffinity column results in T cell depletion equivalent to elutriation. Exp Hematol 1995, 23:320-322.
8. + selected cells from peripheral blood. Blood 1997, 89:3967-3973.
9. + hematopoietic progenitor cells. J Hematother 1994, 3:145-147.
10. + cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia 1999, 13:2070-2078.
11. Handgretinger R., Schumm M., Lang P., et al. Transplantation of megadoses of purified haploidentical stem cells. Ann NY Acad Sci 1999, 872:351-362.
12. Inaba M., Adachi Y., Hisha H., et al. Extensive studies on perfusion method plus intra-bone marrow-bone marrow transplantation using cynomolgus monkeys. STEM CELL. 2007, 25:2098-103.
13. Kushida T., Inaba M., Ikebukuro K., et al. A new method for bone marrow cell harvesting. Stem Cells 2000, 18:453-456.
14. Kushida T., Inaba M., Ikebukuro K., et al. Comparison of bone marrow cells harvested from various bones of cynomolgus monkeys various ages by perfusion or aspiration methods: a preclinical study for human BMT. Stem Cells 2002, 20:155-162.
15. Hashimoto F., Sugiura K., Inoue K., et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro. Blood 1997, 89:49-54.
16. Sugiura K., Hisha H., Ishikawa J., et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro. Stem Cells 2001, 19:46-58.
17. van Hennik P.B., de Koning A.E., Ploemacher R.E. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood 1999, 94:3055-3306.
18. Cashman J.D., Eaves C.J. High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice. Blood 2000, 96:3979-3981.
19. Panoskaltsis-Mortari A., Price A., Hermanson J.R., et al. In vivo imaging of graft-versus-host-disease in mice. Blood 2004, 103:3590-3598.
20. Zhang Y., Yasumizu R., Sugiura K., et al. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: possible explanation for the mechanism of tolerance induction by portal vein injection. Eur J Immunol 1994, 24:1558-1565.
21. Kushida T., Inaba M., Hisha H., et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 2001, 97:3292-3299.
22. Porter K.A. Effect of homologous bone marrow injections in X-irradiated rabbits. Br J Exp Pathol March 1957, 30:401-412.
23. Porter K.A., Murray J.E. Long-term study of X-irradiated rabbits with bone-marrow homotransplants. J Natl Cancer Inst 1958, 20:189-205.
24. Chai C.K. Effect of inbreeding in rabbits: skeletal variation and malformations. J Hered 1970, 61:3-8.
25. Cui W.H., Hosaka N., Miyake T., et al. Analysis of tolerance induction using triple chimeric mice: major histocompatibility complex-disparate thymus, hemopoietic cells, and microenvironment. Transplantation 2008, 85:1151-1158.
26. Markus P.M., Cai X., Ming W., et al. Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats. Transplantation 1991, 52:590-594.
27. Antin J.H., Ferrara J.L. Cytokine dysregulation and acute graft-vs-host disease. Blood 1992, 80:2964-2968.
28. Baker K.S., Allen R.D., Roths J.B., et al. Kinetic and organ-specific patterns of cytokine expression in acute graft-vs-host disease. Bone Marrow Transplant 1995, 15:595-603.
29. Roy J., Blazar B.R., Ochs L., et al. The tissue expression of cytokines in human acute cutaneous graft-vs-host disease. Transplantation 1995, 60:343-348.
30. Ciceri F., Labopin M., Aversa F., et al. A survey of fully-haploidentical hematopoietic stem cells transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients transplanted in remission. Blood 2008, 112:3574-3581.
31. Stern M., Ruggeri L., Mancusi A., et al. Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood 2008, 112:2990-2995.
32. Takeuchi K., Inaba M., Miyashima S., et al. A new strategy for treatment of autoimmune disease in chimeric resistant MRL/lpr mice. Blood 1998, 91:4616-4623.
33. Martin P.J. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J Exp Med 1993, 178:703-712.
34. Tomita Y., Mayumi H., Eto M., et al. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. J Immunol 1990, 144:463-473.
35. Asiedu C., Meng Y., Wang W., et al. Immunoregulatory rule of CD8α in the effect. Transplantation 1999, 67:372-380.
36. Drobyski W.R., Klein J., Flomenberg N., et al. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of recipients of alternative donor grafts. Blood 2002, 99:806-814.
37. Ogawa H., Ikegame K., Kaida K., et al. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Exp Hematol 2008, 36:1-8.
38. Li Q., Hisha H., Yasumizu R., et al. Analysis of very early hemopoietic regeneration after bone marrow transplantation: comparison of intravenous and intrabone marrow routes. Stem Cells 2007, 25:1186-1194.
39. - cells assured by intra-bone marrow injection. Blood 2003, 101:2924-2931.
40. Guo K.Q., Inaba M., Li M., et al. Long-term donor-specific tolerance in rat cardiac allografts by intra-bone marrow injection of donor bone marrow cells. Transplantation 2008, 85:93-101.
41. Esumi T., Inaba M., Ichioka N., et al. Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells. Transplantation 2003, 76:1543-1548.
42. Ikehara S. New strategies for BMT, organ transplantation, and regeneration therapy. Hematology 2003, 8:77-81.
43. Taira M., Inaba M., Baba S., et al. Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two MHC-disparate rats in combination with intra-bone marrow injection of allogeneic bone marrow cells. Transplantation 2005, 79:680-687.